Innes E H
Curr Med Res Opin. 1977;5(1):122-6. doi: 10.1185/03007997709108988.
An open study was carried out in 40 elderly patients suffering from osteoarthrosis of the hip to assess the effectiveness of 200 mg flurbiprofen daily, fiven either in tablet or liquid suspension form, over a period of 4 weeks. Statistical evaluation of the results in the 19 patients admitted to analysis showed that flurbiprofen produced significant improvement in daytime and overnight pain, and did not impair their mental status, as assessed on a modified Goldfarb scale. No significant differences were found between the response of the two groups, except for severity of night pain. Fourteen of the 19 patients included in the analysis reported side-effects, as did 18 of the 21 patients who were excluded. Only 7 patients (4 on tablets, 3 on liquid), however, were withdrawn from the trial for this reason.
对40例老年髋骨关节炎患者进行了一项开放性研究,以评估每日200毫克氟比洛芬(以片剂或液体悬浮液形式给药)在4周内的疗效。对纳入分析的19例患者的结果进行统计评估显示,根据改良的戈德法布量表评估,氟比洛芬可显著改善日间和夜间疼痛,且不损害其精神状态。除夜间疼痛严重程度外,两组的反应未发现显著差异。纳入分析的19例患者中有14例报告了副作用,被排除的21例患者中有18例也报告了副作用。然而,只有7例患者(4例服用片剂,3例服用液体悬浮液)因此退出试验。